Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionCwm, Llc
Latest Disclosed Ownership50,819 shares
Latest Disclosed Value $ 734,843
Cwm, Llc reports 0.06% increase in ownership of FOLD / Amicus Therapeutics, Inc.

On May 14, 2026 - Cwm, Llc filed a 13F-HR form disclosing ownership of 50,819 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $734,843 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 50,788 shares of Amicus Therapeutics, Inc.. The current value of the position is $736,367 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 50,819 31 0.06 735 0.0019
2026-01-26 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 50,788 14,476 39.87 1 0.0020
2025-10-15 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 36,312 26,915 286.42 0 0.0009
2025-07-25 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 9,397 7,502 395.88 0 0.0002
2025-05-01 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,895 1,531 420.60 0 0.0001
2025-02-04 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 364 -1,235 -77.24 0 0.0000
2024-10-08 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,599 156 10.81 0 0.0001
2024-07-10 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,443 -309 -17.64 0 0.0001
2024-04-05 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,752 53 3.12 0 0.0001
2024-02-01 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,699 -49 -2.80 0 0.0001
2023-10-11 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,748 74 4.42 0 0.0001
2023-08-03 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,674 452 36.99 0 0.0001
2023-05-01 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,222 30 2.52 0 0.0001
2023-02-01 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,192 -10 -0.83 0 -100.00 0.0001
2022-10-27 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,202 0 0.00 13 0.00 0.0001
2022-07-28 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,202 -218 -15.35 13 0.00 0.0001
2022-04-21 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,420 -45 -3.07 13 -23.53 0.0001
2022-01-31 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,465 -154,040 -99.06 17 -98.87 0.0001
2021-09-15 2021-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 155,505 0 0.00 1,499 0.00 0.0119
2021-07-29 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 155,505 0 1,499 0.0119
2021-09-15 2021-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 155,505 0 0.00 1,499 0.00 0.0119
2021-04-27 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 148,008 -7,497 1,462 0.0129
2021-09-15 2020-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 155,505 0 0.00 1,499 0.00 0.0119
2021-01-27 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 139,271 -16,234 3,216 0.0301
2021-09-15 2020-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 155,505 0 0.00 1,499 0.00 0.0119
2020-10-19 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 79 -155,426 1 0.0000
2021-09-15 2020-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 155,505 0 0.00 1,499 0.00 0.0119
2020-07-22 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 79 -155,426 1 0.0000
2021-09-15 2020-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 155,505 0 0.00 1,499 0.00 0.0119
2020-04-28 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 79 -155,426 1 0.0000
2021-09-14 2019-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 155,505 0 0.00 1,499 0.00 0.0119
2020-01-27 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 248 -155,257 2 0.0000
2021-09-14 2019-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 155,505 0 0.00 1,499 0.00 0.0119
2021-09-14 2019-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 155,505 0 0.00 1,499 0.00 0.0119
2021-09-02 2019-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 155,505 154,540 16,014.51 1,499 16,555.56 0.0119
2019-04-22 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 965 0 13 0.0003
2019-01-25 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 965 965 9 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.